1、Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM 20-F (Mark One)REGISTRATION STATEMENT PURSUANT TO SECTION 12(b)OR(g)OF THE SECURITIES ACT OF 1934OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended

2、December 31,2022OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934For the transition period from to OR SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGEACT OF 1934Date of event requiring this shell company report Commission file num

3、ber:001-39316 Burning Rock Biotech Limited(Exact name of Registrant as specified in its charter)N/A(Translation of Registrants name into English)Cayman Islands(Jurisdiction of incorporation or organization)No.5,Xingdao Ring Road North,International Bio Island,Guangzhou,510005The Peoples Republic of

4、China(Address of principal executive offices)Mr.Leo Li,Chief Financial OfficerTelephone:+86 020-3403 7871 Email:No.5,Xingdao Ring Road North,International Bio Island,Guangzhou,510005The Peoples Republic of China(Name,Telephone,E-mail and/or Facsimile number and Address of Company Contact Person)Secu

5、rities registered or to be registered,pursuant to Section 12(b)of the Act.Title of each class TradingSymbol Name of each exchangeon which registeredAmerican depositary shares,each representingone Class A ordinary share BNR The Nasdaq Stock Market LLC(The Nasdaq Global Market)Class A ordinary share,p

6、ar value US$0.0002per share*The Nasdaq Stock Market LLC(The Nasdaq Global Market)American depositary shares,each representingone Class A ordinary share BNR London Stock Exchange(The Main Market)*Not for trading,but only in connection with the listing of the Nasdaq Global Market of American depositar